Web Results

Nilotinib

en.wikipedia.org/wiki/Nilotinib

Nilotinib (AMN107, trade name Tasigna), in the form of the hydrochloride monohydrate salt, is a small-molecule tyrosine kinase inhibitor approved for the ...

Nilotinib: MedlinePlus Drug Information

medlineplus.gov/druginfo/meds/a608002.html

Nilotinib may cause QT prolongation (an irregular heart rhythm that can lead to fainting, loss of consciousness, seizures, or sudden death). Tell your doctor if you  ...

FDA Approval for Nilotinib - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/fda-nilotinib

Jul 3, 2013 ... Information from the FDA about the approval of nilotinib and the clinical trials that led to the approval.

Nilotinib - National Cancer Institute

www.cancer.gov/about-cancer/treatment/drugs/nilotinib

This page contains brief information about nilotinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...

TASIGNA - Novartis

hcp.novartis.com/products/tasigna/

TASIGNA<sup>®</sup> (nilotinib) is indicated for the treatment of newly diagnosed adult patients with Philadelphia chromosome–positive chronic myeloid leukemia (Ph+  ...

Nilotinib | C28H22F3N7O - PubChem

pubchem.ncbi.nlm.nih.gov/compound/Nilotinib

Nilotinib | C28H22F3N7O | CID 644241 - structure, chemical names, physical and chemical properties, classification, patents, literature, biological activities, ...

Nilotinib (Tasigna) | Cancer Research UK

www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/cancer-drugs/nilotinib

Jan 2, 2015 ... Read about the cancer treatment drug nilotinib, otherwise known as Tasigna, including what it is, how it works and possible side effects.

Tasigna Capsules (Nilotinib Capsules): Side Effects, Interactions ...

www.rxlist.com/tasigna-drug.htm

Nov 30, 2015 ... Learn about Tasigna Capsules (Nilotinib Capsules) may treat, uses, dosage, side effects, drug interactions, warnings, patient labeling, reviews, ...

Nilotinib: a second-generation tyrosine kinase inhibitor for the ...

www.ncbi.nlm.nih.gov/pubmed/19108785

BACKGROUND: Nilotinib, a second-generation tyrosine kinase inhibitor (TKI) formerly known as AMN107, was approved by the US Food and Drug ...

Nilotinib: a novel, selective tyrosine kinase inhibitor. - NCBI

www.ncbi.nlm.nih.gov/pubmed/21419934

Semin Oncol. 2011 Apr;38 Suppl 1:S3-9. doi: 10.1053/j.seminoncol.2011.01.016. Nilotinib: a novel, selective tyrosine kinase inhibitor. Blay JY(1), von Mehren M.

More Info

Tasigna - Home

www.tasigna.com

... of Product Characteristics; Print. TASIGNA (nilotinib) .... TASIGNA<sup>®</sup> (Nilotinib) is approved for use in 110 countries around the world. Healthcare Professionals  ...

Should Patients and Families Be Considering Tasigna (Nilotinib ...

www.parkinson.org

Should Patients and Families Be Considering Tasigna (Nilotinib) Therapy for ... Tasigna (Nilotinib) is a leukemia drug that has recently been tested for safety in a  ...

Tasigna - Novartis

www.pharma.us.novartis.com

See full prescribing information for. TASIGNA. TASIGNA® (nilotinib) Capsules for oral use. Initial U.S. Approval: 2007. WARNING: QT PROLONGATION AND ...